Our results showed a crosstalk between PI3K/Akt and ERK since treatment with wortmannin and ATRA was able to increase the ERK phosphorylation and conversely the MEK inhibitor avoids the AKT phosphorylation in lung cancer cells. Here, MAP2K7 is linked to lung carcinoma.